Inhaled corticosteroids
Pro Research Analysisby 
Searched over 200M research papers for "inhaled corticosteroids"
The Role and Impact of Inhaled Corticosteroids in Respiratory Conditions
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)
Efficacy in Reducing Exacerbations and Mortality
Inhaled corticosteroids (ICS) are widely used in the management of chronic obstructive pulmonary disease (COPD). Research indicates that ICS can significantly reduce the rate of exacerbations in COPD patients. A systematic review of randomized placebo-controlled trials found that ICS therapy reduced exacerbation rates by 30% (RR = 0.70; 95% CI: 0.58 to 0.84) . Another comprehensive review confirmed these findings, showing a reduction in exacerbation rates by 0.26 per patient per year (95% CI: -0.37 to -0.14) . However, the impact of ICS on mortality remains inconclusive, with no significant effect observed in multiple studies (RR = 0.84; 95% CI: 0.60 to 1.18) 12.
Side Effects and Risks
While ICS are beneficial in reducing exacerbations, they are associated with several side effects. Increased rates of oropharyngeal candidiasis (RR = 2.1; 95% CI: 1.5 to 3.1) and skin bruising (RR = 2.1; 95% CI: 1.6 to 2.8) have been reported . Additionally, long-term use of ICS in COPD patients has been linked to an increased risk of pneumonia (OR 1.56, 95% CI 1.30 to 1.86) . These side effects necessitate a careful evaluation of the benefit-risk ratio when prescribing ICS for COPD.
Inhaled Corticosteroids in Asthma
Effectiveness in Asthma Management
ICS are the cornerstone of asthma management due to their potent anti-inflammatory properties. They effectively reduce airway hyperresponsiveness and control asthma symptoms by suppressing multiple activated inflammatory genes . Studies have shown that ICS improve lung function and reduce bronchial hyperreactivity more effectively than beta2-agonists . Furthermore, ICS therapy increases the release of anti-inflammatory cytokines like interleukin-10 while reducing pro-inflammatory cytokines, contributing to their beneficial effects in asthma .
Patient Compliance and Inhalation Technique
The effectiveness of ICS in asthma is significantly influenced by patient compliance and inhalation technique. A systematic review highlighted that patients adhered to their prescribed ICS regimen on only 20 to 73% of days, and efficient inhalation technique was observed in 46 to 59% of patients . Education programs have been shown to improve both compliance and inhalation techniques, thereby enhancing the therapeutic outcomes of ICS therapy .
Impact on Growth in Children
The use of ICS in children with persistent asthma raises concerns about potential adverse effects on growth. A review of randomized controlled trials found that different ICS drugs and delivery devices have varying impacts on linear growth. Fluticasone, for instance, was associated with less growth suppression compared to beclomethasone and budesonide . However, the evidence is not robust enough to definitively guide the selection of ICS or inhalation devices based on growth impact alone .
Inhaled Corticosteroids in Preterm Neonates
Prevention of Chronic Lung Disease
Inhaled corticosteroids have also been investigated for preventing chronic lung disease (CLD) in very low birth weight (VLBW) preterm neonates. Early administration of ICS in these infants has shown a significant reduction in the incidence of CLD at 36 weeks' postmenstrual age (PMA) among survivors (RR 0.76, 95% CI 0.63 to 0.93) . Additionally, there was a notable reduction in the combined outcome of death or CLD at 36 weeks' PMA (RR 0.86, 95% CI 0.75 to 0.99) . These findings suggest that early ICS therapy can be beneficial in this vulnerable population, although further studies are needed to fully understand the long-term effects.
Conclusion
Inhaled corticosteroids play a crucial role in managing various respiratory conditions, including COPD, asthma, and CLD in preterm neonates. While they offer significant benefits in reducing exacerbations and controlling symptoms, their use is accompanied by potential side effects that must be carefully considered. Ongoing research and patient education are essential to optimize the therapeutic outcomes of ICS therapy and minimize associated risks.
Sources and full results
Most relevant research papers on this topic